Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAnxiety is not listed as a common side effect of Mounjaro (tirzepatide) in the UK prescribing information, but some people do report feeling anxious or on edge after starting treatment. Understanding why that happens, and when it matters, is the most useful thing you can do. Mounjaro is a prescription-only medicine requiring clinical assessment before anyone can be prescribed it.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When patients search for information on Mounjaro's side effects, anxiety tends to be high on their list, partly because online forums amplify individual experiences. The factual starting point is the UK Summary of Product Characteristics (SmPC) for tirzepatide, held on the Electronic Medicines Compendium. The very common and common side effects listed there are overwhelmingly gastrointestinal: nausea, diarrhoea, vomiting, constipation, indigestion. Dizziness, fatigue and headache also feature. Anxiety does not appear in those tiers.
That does not mean it cannot happen. The SmPC also records uncommon and rare events where the evidence base is thinner, and post-marketing reports can surface effects that larger trials did not capture at a statistically significant rate. The NHS medicines page for tirzepatide gives a plain-English summary of the same risk hierarchy. Anyone wondering specifically whether Mounjaro can cause anxiety will find a detailed evidence-based answer on that page before drawing conclusions. If anxiety still doesn't explain what you are feeling, the next step is working out which indirect mechanism might.
Several things that tirzepatide does to the body can produce anxiety-like sensations without acting directly on mood pathways. Recognising them is genuinely useful.
Blood sugar fluctuations. Mounjaro slows gastric emptying and dampens appetite. If someone eats significantly less than usual, particularly skipping carbohydrates, blood glucose can drop lower than the body is used to. The classic response to a blood-sugar dip (shakiness, a racing heart, a sense of unease) feels a great deal like anxiety. Keeping the tablet or pen record next to your diary (or, practically, your pen in the fridge door you open most mornings) makes it easier to connect symptoms to dose timing.
Caffeine sensitivity. Slower gastric emptying means coffee and other stimulants are absorbed differently. The same cup that felt fine before treatment can hit harder, and the physical effects of extra caffeine (elevated heart rate, jitteriness) are hard to distinguish from anxious feelings.
Rapid early weight loss. Significant calorie restriction and weight change affect hormones, sleep quality and energy. Poor sleep, which is common during the early weeks of any major dietary change, is itself a reliable driver of next-day anxiety.
The question of why Mounjaro can cause anxiety in some individuals is explored in more depth on a dedicated page if you want the mechanistic detail.
Mild unease in the first week or two after a dose increase is not unusual, most people's bodies settle. Anxiety that persists beyond two weeks, feels severe, or arrives alongside low mood or thoughts of self-harm is a different matter entirely. Contact your prescriber the same day if that is what you are experiencing. Worsening anxiety on Mounjaro should always be assessed clinically rather than managed by self-adjusting your dose.
A few other signals worth acting on promptly: palpitations that are sustained rather than brief, chest tightness, or a feeling that something is physically wrong rather than emotionally unsettled. These can overlap with anxiety but may point to something else. The MHRA asks patients to report any suspected side effects (including psychological ones) through the Yellow Card scheme; reports from real-world patients help regulators track emerging signals before they reach the prescribing information.
It is also worth knowing that pre-existing anxiety disorders do not automatically rule someone out from tirzepatide, but they do need to be part of the clinical conversation. A prescriber who knows your full history can weigh the benefit against any additional monitoring you might need. For context on how treatment cost fits into broader planning, the Mounjaro cost page covers what private prescriptions typically include.
The more specific you can be, the easier it is for a clinician to help. Useful things to note: when the anxious feelings start relative to your weekly injection (or daily tablet if you are on a different preparation), whether they coincide with meals or fasting periods, how your sleep has been, and whether caffeine or alcohol intake has changed. That pattern tells a different story from anxiety that sits at a constant background level regardless of timing.
Your prescriber may consider whether a slower dose titration would allow your system more time to adjust, or whether something in your lifestyle during the early weeks is amplifying the effect. They will not simply tell you to stop; anxiety as a reported side effect has a range of management options depending on the cause. The clinical team at nume reviews every patient's progress before each repeat prescription, which means concerns raised between orders are taken into account for the next clinical decision, not stored away. If you have questions now, our support team is available seven days a week.
If you are considering starting tirzepatide and want to discuss how it might interact with an existing anxiety condition, speaking to our prescribers is the right place to begin.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.